Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses
…as a therapeutic to combat SARS-CoV-2 infection. We provided a proof of principle demonstration that TEAR-CoV-based RNA engineering approach leads to RNA-guided transcript degradation both in vitro and in eukaryotic…